|
|
Volumn 28, Issue 4, 1996, Pages 275-
|
|
Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEUROPROTECTIVE AGENT;
RILUZOLE;
THIAZOLE DERIVATIVE;
AMYOTROPHIC LATERAL SCLEROSIS;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOUBLE BLIND PROCEDURE;
HUMAN;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TRACHEOSTOMY;
AMYOTROPHIC LATERAL SCLEROSIS;
DOUBLE-BLIND METHOD;
HUMANS;
NEUROPROTECTIVE AGENTS;
RANDOMIZED CONTROLLED TRIALS;
RILUZOLE;
SURVIVAL ANALYSIS;
THIAZOLES;
TRACHEOSTOMY;
|
|
EID: 0030202676
PISSN: 08880395
EISSN: None
Source Type: Journal
DOI: 10.1097/01376517-199608000-00017 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|